BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4522066)

  • 21. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Systemic collateral effects of intermittent antituberculous treatments with rifampicin].
    Decroix G; Pujet JC
    Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):733-43. PubMed ID: 5151216
    [No Abstract]   [Full Text] [Related]  

  • 24. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 26. A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
    Lee SK
    Bull Int Union Tuberc; 1976; 51(1):109-13. PubMed ID: 1030269
    [No Abstract]   [Full Text] [Related]  

  • 27. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG; Esanbaev DE; Kirina SB
    Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thrombocytopenia caused by hypersensitivity to rifampicin in intermittent high doses].
    Sepúlveda R; Soerensen R; Santiviago C; Alvarez R; Gay O; Zúñiga E; Meléndez M; Farga V
    Rev Med Chil; 1971 Dec; 99(12):934-8. PubMed ID: 5168230
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 32. [Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
    Hinaut G; Bosio AM; Estampes B
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):291-5. PubMed ID: 5510315
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Gomi J; Aoyagi T
    Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 39. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.